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in that it has a skirt designed to prevent paravalvular leak, improved coaxial
alignment, and more accurate positioning.
Aims To evaluate paravalvular aortic regurgitations after 30-day after
TAVI using the Edwards SAPIEN 3 prosthesis.
Methods Prospective monocentric study including 66 high-risk or non-
operable patients with severe aortic stenosis undergoing TAVI using Edwards
SAPIEN 3 prosthesis via transfemoral access, between September 2014 and
March 2015.
Results Mean age of patient was 84±7,1 years (70% female). The MDCT
estimated an aortic annular diameter 25,07±2mm. Mean logistic EuroSCORE
was 15,8±10,8. In our study, the device success rate was 98.5%. The pros-
thesis has been deployed correctly in all cases and no failure of valve or
embolization had occurred. Post TAVR, mean transaortic gradient decreased
from 46,0±12,33mmHg to 8,2±3,37mmHg (p<0.001). No patient had mod-
erate or severe PAR. At 30 days follow up, transthoracic echocardiography
(TTE) showed that the PAR was absent or trivial in 66% of patients and mild
in the remainder. Possible reasons for this low PAR rate include: 1) the outer
polyethylene terephthalate sealing cuff, which enhances paravalvular sealing;
2) more accurate positioning; and 3) improved sizing with adjunctive MDCT.
Conclusion In our study, TAVI with Edwards SAPIEN 3 demonstrated
lower paravalvular aortic leak rates than earlier generation devices in patients
at high risk for surgery.
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Introduction Prosthetic valve endocarditis (PVE) is an uncommon
complication after valve replacement surgery, but potentially fatal. The scar-
city of clinical trials makes harder the diagnostic and therapeutic approach of
this entity. 
Aim To define the clinical characteristics and in-hospital evolution of a
population with PVE. 
Methods Retrospective study based on a sample of 173 patients (P) with
the diagnosis of infective endocarditis (IE), according to the modified Duke
criteria, admitted from 1998 to 2013. We analyzed demographic and clinical
features, complications and in-hospital mortality of P with PVE. 
Results We found 34 P (20%) with PVE, mean age 60.2±17.6 years with
a female predominance (53%). The most common form was the community-
acquired IE, registering 11 P (32%) with health care-associated IE. There was
a preferential engagement of the mitral valve (56%) and 26% had early PVE. 
The cardinal complaints at presentation were constitutional symptoms (97%)
and fever (74%); 50% of P showed signs of acute heart failure (HF). The most
common analytical abnormalities were elevated inflammatory biomarkers (CRP
94% and leukocytosis 41%), anemia (88%) and increased creatinine (60%). 
The microbial agent was isolated in 24 P (71%), being Staphylococcus spp
(26%) and Streptococcus spp (21%) the most common. 
The prosthesis dehiscence (60%), severe regurgitation (29%) and perival-
vular abscess (21%) were the most frequent complications seen at initial echo-
cardiographic evaluation. 
The most common adverse events were acute kidney injury (74%), per-
sistence of HF (56%), septic shock (15%) and stroke (12%). There was need
for urgent referral to surgery in 38% of P. The in-hospital mortality was
higher than other P with IE (21% vs 13%). 
Conclusion The PVE is associated with a poor prognosis at short term. Its
adverse developments should lead to the early identification of riskier P and
timely consideration of the possible benefit of surgery.
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Introduction The main etiology of mitral stenosis is rheumatic fever. There
remains a significant problem in developing countries and persists also in
developed countries despite a marked decline in prevalence in recent decades.
It mainly affects young adults, however it changes clinical presentation in
older patients with more altered valvular anatomy. The objective of this work
is to analyze the particularity of the mitral stenosis in the Moroccan elderly
over 50 years.
Materials and methods This is a descriptive and analytical retrospective
study, conducted in Ibn Rochd Center of Cardiology from January to June
2014, which included 45 patients with a sever mitral stenosis, devided into
2 groups: Group I: 24 patients <50 years group II: 21 patients ≥50ans. 
Statistical analysis was performed on IBM SPSS Statistics 20.
Results In our series there was a female predominance in the 2 groups (79%
vs 62%, group I, group II). In patients over 50 years, the atrial fibrillation was
more common (50% vs 70%) (p: 0.005), left atrium was more dilated (p 0.05 for
the diameter of the OG, and p: 0.046 to the surface of the OG), average gradient
was higher (p 0.044), the valves were more calcified (p:0.02), the history percuta-
neous mitral dilation was more frequent in group II (p: 0.009).
Conclusion The mitral stenosis of elderly has more impact on the cardiac
arrhythmia, the size of the OG, the severity of the gradient, and on valvular
anatomy that is more calcified.
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Objectives Valvular heart disease still common despite improved health
conditions that have reduced the incidence of rheumatic fever. Surgical and
interventional indications have expanded and today we operate at early stages,
sometimes even an asymptomatic stage. Valvular reoperation is required in
about 15% of cases during the evolution of an operated valve disease. We
report in this study the results of surgical valvular reoperations to identify the
indications for these reoperations.
Methods This is a retrospective study of 45 patients aged between 18 and 70
years, admitted to the cardiology department from January 2011 to July 2013,
and having a valve disease already operated and requiring reoperation.
Results Our series consisted of 45 patients; the average age is 41 years.
73% of patients are women and 27% of men (sex ratio of 3). The mitral valve
reoperations are motivated in most cases by a restenosis after a surgical com-
missurotomy (84%) and in 7% of cases by a prosthetic dysfunction, while
aortic valve reoperations are represented primarily by the dysfunction of pros-
thesis (44%) and aortic regurgitation neglected (56%). Finally, the reoperation
on the tricuspid valve is dominated essentially by regurgitation neglected
during the first intervention (62%). The average time between the two inter-
ventions, any kind confused, is 21 years, but this “timing” is variable if we
take into consideration the repair technique.
Conclusion Cardiac reoperations may occur during the evolution of a
valvulopathy. The patient should be warned of this and the possibility of
reoperation should be considered at the first cardiac surgery. Good initial car-
diac evaluation is needed to overcome the risk of reoperation for valve disease
neglected. 
Keywords reoperation, prosthesis dysfunction, degeneration, bioprostheses,
valvuloplasty, commissurotomy. 
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